Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. Every year, Drug Channels reviews drug pricing trends at the largest pharmaceutical man…
The WeekDrug Channels ↗
By Adam J. Fein, Ph.D. Every year, Drug Channels reviews drug pricing trends at the largest pharmaceutical man…
The WeekPharmaceutical Technology ↗
BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within t…
The WeekSTAT News ↗
A coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs aimed at lowe…
The WeekBioPharma Dive ↗
Tempus AI's planned acquisition follows recent interest in blood-based cancer tests across the medtech industr…
The WeekPharmaVoice ↗
The strain causing the current outbreak has no approved treatments or vaccines but global organizations are ru…
The WeekFiercePharma ↗
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufac…
The WeekFierceBiotech ↗
After Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last …
The WeekBriefing
CMS and state actions under the American Rescue Plan Act and later legislation have made yearlong postpartum c…
The WeekBriefing
The FDA approved Merck’s Lipfendra under a voucher program launched by former commissioner Marty Makary, marki…
The WeekSTAT News ↗
"Pandemics should be viewed and combated as threats to national security," write David Blumenthal and James A.…
The WeekFiercePharma ↗
In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansion…
The WeekFierceBiotech ↗
Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease biotech Kira Pharm…
The WeekBriefing
Veradermics' oral minoxidil exceeded expectations in Phase 2, sending shares near $130 and strengthening its c…
The WeekSTAT News ↗
"I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended conse…
The WeekFiercePharma ↗
The FDA has converted its accelerated approval for Novartis' Fabhalta into a full blessing to treat patients w…
The WeekFierceBiotech ↗
Another biotech is squeezing into the crowded IPO waiting room just in time for the weekend. BlossomHill Thera…
The WeekBriefing
The European Commission cleared Novo Nordisk’s oral Wegovy, giving the company a head start over Eli Lilly’s s…
The WeekSTAT News ↗
"The real opportunity is to move beyond policies and narratives that pit specialties against one another," pre…
The WeekBioPharma Dive ↗
The acquisition, which involves a concurrent licensing deal with startup Mirador, gives Jasper a chance to reb…
The WeekBioPharma Dive ↗
The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a proli…
The WeekPharmaVoice ↗
Why building relationships, navigating cultural nuances and preparing for different deal structures are key to…
The WeekBioPharma Dive ↗
Mixed Phase 3 data for camlipixant prompted the British pharma to cease development, making the drug the third…
The WeekPharmaVoice ↗
Despite an FDA crackdown and numerous pharma lawsuits, nearly 1 in 5 patients are taking cheaper weight-loss a…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.